Whitepapers

Whitepaper Aug 8, 2023

CAR T-Cell Therapies in the US, UK and EU4

Whitepaper Jul 13, 2023

Making a Case for Using Real World Data to Model Patient Entry in Budget Impact Analyses

Whitepaper Jul 12, 2023

The Impact of Social Media in Healthcare: a Catalyst For Stigmatization of GLP-1 Receptor Agonists Usage

Whitepaper Jul 12, 2023

The Strategic Narrative Thread: Connecting brand messaging and execution

Whitepaper Jul 5, 2023

A Practical Guide to Segmentation: What, who, why, and how?

Whitepaper Jun 28, 2023

Scenario-based Strategy in Tumultuous Times: How pharma executives can conquer uncertainty

Whitepaper Jun 27, 2023

The Challenges of Robustly Estimating Relative Effects on Adverse Events and Discontinuations Via an Indirect Treatment Comparison

Whitepaper Jun 26, 2023

Navigating New Competitive Crosswinds: How Pharma Can Plan for Success

View Jun 14, 2023

Opportunities for Enhanced Communication between Manufacturers and US Payers

Whitepaper May 31, 2023

Overcoming Challenges in Demonstrating the Value of Drugs for Treating Rare Diseases

Whitepaper Mar 31, 2023

Facing Up to the Challenges of EU Joint Clinical Assessments

Whitepaper Jan 18, 2023

Do You Really Know How Your Market Works?

Whitepaper Dec 13, 2022

The Launch Rollercoaster: Riding the highs and lows

Whitepaper Dec 5, 2022

The story behind the numbers: How burden of illness studies add value to HTA submissions

Whitepaper Nov 10, 2022

Medical Strategy: How Medical Affairs Creates Alignment and Demonstrates Value

Whitepaper Nov 9, 2022

Optimizing Launch Commercialization of Cell and Gene Therapies: Charting a Path to Success

1 2 3 4 5 6 7